Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin. (Q42980561)
Jump to navigation
Jump to search
scientific article published on 18 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin. |
scientific article published on 18 May 2012 |
Statements
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin (English)
Olivier Boillot
Christophe Duvoux
Georges Pageaux
Philippe Wolf
Claire Vanlemmens
Danielle Botta-Fridlund
Martine Néau-Cransac
Olivier Chazouillères
Laurence Samelson
Karim Boudjema
Lionel Rostaing